化合物FLT3-IN-1 T2051
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 1370256-78-2 | ¥6,980.00 | 询底价 |
50 mg | 1370256-78-2 | ¥4,890.00 | 询底价 |
25 mg | 1370256-78-2 | ¥3,360.00 | 询底价 |
1 mL | 1370256-78-2 | ¥1,620.00 | 询底价 |
5 mg | 1370256-78-2 | ¥1,370.00 | 询底价 |
2 mg | 1370256-78-2 | ¥913.00 | 询底价 |
10 mg | 1370256-78-2 | ¥1,980.00 | 询底价 |
1 mg | 1370256-78-2 | ¥621.00 | 询底价 |
500 mg | 1370256-78-2 | ¥13,900.00 | 询底价 |
Product Introduction
Bioactivity
英文名: SKLB4771
描述: SKLB4771 (FLT3-IN-1) 是一种新型的、高效的 Flt3 抑制剂 (IC50:10nM)。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (93 mM)
关键字: inhibit | cell proliferation inhibition | selective | c-Kit | Inhibitor | Cluster of differentiation antigen 135 | SKLB4771 | FLT3 | CD135 | Fms like tyrosine kinase 3 | apoptosis induction | SKLB-4771 | SKLB 4771 | phosphorylation | CD117 | SCFR
相关产品: Brigatinib | NCT-503 | Sorafenib tosylate | CYC-116 | Sitravatinib | Merestinib | Crotonoside | BMS-2 | GSK-1070916 | Tandutinib
相关库: Angiogenesis related Compound Library | Anti-Cancer Compound Library | Anti-Lung Cancer Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Inhibitor Library | Tyrosine Kinase Inhibitor Library | Target-Focused Phenotypic Screening Library | NO PAINS Compound Library | Covalent Inhibitor Library
化合物FLT3-IN-1 T2051信息由TargetMol中国为您提供,如您想了解更多关于化合物FLT3-IN-1 T2051报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途